Muriel Liberto, Mintz
Michael Baran, Pfizer Ventures and Chris Barnstable-Brown, WilmerHale
Steve O'Loughlin, Actinium Pharmaceuticals and Sue Crinnion, JP Morgan Chase
Charlotte D'Hulst, Yesse Technologies and Mary Howard
Michael Baran, Pfizer Ventures
Preparing for Due Diligence workshop, 6.27.19
Craig Keneski, WSGR; Philip Glick, Conner Strong; Phil Bergamo, EisnerAmper
Peikwen Cheng, Yiviva and Craig Kenesky, WSGR
Michael Osso,Crohn's & Colitis Foundation, Chad Dyar, Theraputix and Nini Fan
Mary Howard, ElabNYC | ABCT and Nini Fan and Joseph Morin
Rotem Lev-Zwickel, Agamon and Matt McCambridge, Eden Health
Omar Green, Ionica Sciences and Mary Howard, ElabNYC | ABCT
Krista Fretes, Gentroma
Preparing for Due Diligence workshop, 6.27.19
Fiona Mack, Roche
Fiona Mack, Roche
Steve O'Loughlin, Actinium Pharmaceuticals
John Pennet, EisnerAmper
Sue Crinnion, JP Morgan Chase
Chris Barnstable-Brown ,WilmerHale
Craig Kenesky, WSGR
Phil Bergamo, EisnerAmper
Philip Glick, Conner Strong, Phil Bergamo, EisnerAmper and Scott Matarese, Willis Towers Watson
Mary Howard, ElabNYC | ABCT
Michael Osso, Crohn's & Colitis Foundation's, Sophia Cacciatore, NYCEDC and Jason Campbell, Global Symmetry
Barry Kappel, Sapience Therapeutics
Dennis Purcell, Aisling Capital
Dennis Purcell, Aisling Capital
John Bradley, Torreya Partners
John Bradley, Torreya Partners
Preparing for Due Diligence workshop, 6.27.19
Lambert Edelman and Krista Fretes, Gentroma
Raymond Alvarez, Ichor Biologics, Amit Bansal, and Amit Bansal, Digitalis Ventures and Bruce Nemlich, Nemlich BioPharm and Michael Baran, Pfizer Ventures
Mary Howard, ElabNYC | ABCT
Preparing for Due Diligence workshop, 6.27.19
Lambert Edelman and Michael Barran, Pfizer Ventures
Abby Roberts, Merill Corporation and Chouckri Ben Mamoun, eliv5therapeutics
Jordan Frey, EisnerAmper
Preparing for Due Diligence workshop, 6.27.19
Alan Wink, EisnerAmper, , John Bradley, Torreya Partners, Matt McCambridge, Eden Health and Alan Shaw, Sirnaomics
Alan Wink, EisnerAmper and Mary Howard, ElabNYC | ABCT
Sonia Gonzalez, StudentBody
John Pennett, EisnerAmper
Steve O'Loughlin, Actinium Pharmaceuticals
Fiona Mack, Roche
Muriel Liberto, Mintz
Amit Bansal, Digitalis Ventures, Fiona Mack, Roche and Steve O'Loughlin, Actinium Pharmaceuticals
Thjis Spoor, AzurX BioPharma
Michael Baran, Pfizer Ventures
Sue Crinnion, JP Morgan Chase
Scott Matarese, Willis Towers Watson
Philip Glick, Conner Strong
Scott Matarese, Willis Towers Watson
Jason Campbell, Global Symmetry
Sophia Cacciatore, NYCEDC
Yaniv Sneor, MABA
Alan Roemer, Roivant Sciences
Matt McCambridge, Eden Health
Alan Wink, EisnerAmper
Matt McCambridge, Eden Health
Harold Hess and Jordan Frey, EisnerAmper
Fiona Mack, Roche
Preparing for Due Diligence workshop, 6.27.19
Chris Barnstable-Brown, WilmerHale, Thjis Spoor, AzurRX BioPharma, Sundeep Bhan, Prognos, Sue Crinnion, JP Morgan Chase and Michael Baran, Pfizer Ventures
Mary Howard, ElabNYC | ABCT and Philip Glick, Conner Strong
Jon Zaikowski, CapCell Biologics and Donal Fishbein, Evolve Therapeutics
Mary Howard, ElabNYC Program Director, Chouckri Ben Mamoun, eliv5therapeutics and John Pennett, EisnerAmper
Barham Marami and Reza Royaee, Dispomeds
"Fireside Chat" with Dennis Purcel, Aisling Capital and Alan Roemer, Roivant Sciences
Mary Howard, ElabNYC | ABCT and John Bradley, Torreya Partners
Mary Howard, ElabNYC | ABCT and Matt McCambridge, Eden Health
Chad Dyar, Theraputix, Sonia Gonzalez, StudentBody and Mican Meneses, Menopal
Mary Howard, ElabNYC | ABCT
Muriel Liberto, Mintz; Amit Bansal, Digitalis Ventures; Fiona Mack, Roche; Steve O'Loughlin, Actinium Pharmaceuticals
Amit Bansal, Digitalis Ventures
Muriel Liberto, Mintz, Amit Bansal, Digitalis Ventures, Fiona Mack, Roche and Steve O'Loughlin, Actinium Pharmaceuticals
Mary Howard, ElabNYC Program director
Sundeep Bhan, Prognos
Evan Myrianthopoulos, GPB Capital
Sue Crinnion, JP Morgan Chase
Phil Bergamo, EisnerAmper
Abby Robberts, Merril Corporation
Philip Glick, Conner Strong
Michael Osso, Crohn's & Colitis Foundation's
Meghan Cross Breeden, AmplifyHer Ventures
John Pennett, EisnerAmper
Alan Roemer, Roivant Sciences
Matt McCambridge, Eden Health
Alan Wink, EisnerAmper, John Bradley, Torreya Partners, Matt McCambridge, Eden Health and Alan Shaw, Sirnaomics
Matt McCambridge, Eden Health
Entrepreneurship Lab
BIO AND HEALTH TECH NYC
Corporate Supporters
Community Service Providers
ELabNYC is a Program of
Initiated by
Copyright © 2018 Entrepreneurship Lab NYC